A TEXTBOOK ON ANTI-CONVULSANT BILAYER TABLETS

-15% su kodu: ENG15
48,81 
Įprasta kaina: 57,42 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
48,81 
Įprasta kaina: 57,42 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
2025-02-28 57.4200 InStock
Nemokamas pristatymas į paštomatus per 11-15 darbo dienų užsakymams nuo 10,00 

Knygos aprašymas

Since the advancement cost of another medication particle is exceptionally high, endeavors are presently being made by drug organizations to zero in on the improvement of new medication measurements structures for known medications with changed wellbeing and viability along with diminished dose recurrence, and to create savvy dosage form. Bi-layered tablet idea has for quite some time been used to create continued delivered detailing. The ADME advantage depends on model that, drug discharge from the fast delivering layer prompts an unexpected ascent in the blood fixation. Anyway the blood level is kept up at consistent state as the delivery from continued layer. Especially bilayer tablets are normally used to maintain a strategic distance from synthetic inconsistencies of detailing segments by physical detachment, and delivery profile. After feed and dementias, epileptic seizures establish the third most incessant neurologic issues experienced in older in created countries. Best details for every layers had chosen for the bi-layered tablet and this bi-layered tablets was then readied. Divalproex sodium bi-layered tablet had exposed to weight variety, hardness, etc.

Informacija

Autorius: Raksha Goswami, Deepak Kumawat, Shelendra Kumar Manglavat,
Leidėjas: LAP LAMBERT Academic Publishing
Išleidimo metai: 2021
Knygos puslapių skaičius: 64
ISBN-10: 6203307432
ISBN-13: 9786203307436
Formatas: 220 x 150 x 4 mm. Knyga minkštu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „A TEXTBOOK ON ANTI-CONVULSANT BILAYER TABLETS“

Būtina įvertinti prekę

Goodreads reviews for „A TEXTBOOK ON ANTI-CONVULSANT BILAYER TABLETS“